886 results
Page 2 of 45
SC TO-T/A
EX-99
uhy ntqh8
12 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.1
gdt0jk6yq4u1
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
i7pynu6o7x167
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
8urmeaoectqxpi
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
lm71s5do4az w1hl
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
seen69t8
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
73qjc1
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
s74uug
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
phb0sb j1mi
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
j60 gzpt1a7
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
4e05je
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
o585twp943
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
EX-99.1
vuu r6ilascvc4
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
cd5m4ptbjfj9hed7wt
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.1
wlajintagyczpw s9biz
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-1.1
m81b580555qtx22 i2
13 Nov 23
Other Events
4:19pm
8-K
EX-4.1
445jop3
13 Nov 23
Other Events
4:19pm
424B5
pnv2y6 mv8c8mbt5
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
w70kcyf1smsopeiz
30 Oct 23
Prospectus supplement
8:05am